Systematic validation of hypothesis-driven candidate genes for cervical cancer in a genome-wide association study

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 2084-2088

  Johanneson, Bo ^a   Chen, Dan ^a   Enroth, Stefan ^a   Cui, Tao ^a   Gyllensten, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; DEAD BOX PROTEIN; EXONUCLEASE; OSTEOPONTIN; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; META ANALYSIS (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; UTERINE CERVIX CANCER; VALIDATION STUDY; VIRUS ONCOGENE;

CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 84906833763     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu125     Document Type: Article

References (25)

1. Zehbe,I. et al. (1997) Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology. J. Pathol., 181, 270-275.
2. Veldhuijzen,N.J. et al. (2010) Factors affecting transmission of mucosal human papillomavirus. Lancet Infect. Dis., 10, 862-874.
3. Bosch,F.X. et al. (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine, 26(suppl. 10), K1-K16.
4. Hildesheim,A. et al. (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res., 89, 229-240.
5. Zoodsma,M. et al. (2005) HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease. Int. J. Oncol., 26, 769-784.
6. Ellis,J.R. et al. (1995) The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med., 1, 464-470.
7. Engelmark,M. et al. (2004) Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum. Mol. Genet., 13, 1951-1958.
8. Chen,X. et al. (2011) Genetic susceptibility of cervical cancer. J. Biomed. Res., 25, 155-164.
9. de Freitas,A.C. et al. (2012) Susceptibility to cervical cancer: an overview. Gynecol. Oncol., 126, 304-311.
10. Schork,N.J. et al. (2001) The future of genetic case-control studies. Adv. Genet., 42, 191-212.
11. Klug,S.J. et al. (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol., 10, 772-784.
12. Chen,D. et al. (2013) Genome-wide association study of susceptibility loci for cervical cancer. J. Natl. Cancer Inst., 105, 624-633.
13. Zoodsma,M. et al. (2005) Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J. Med. Genet., 42, e49.
14. Shi,Y. et al. (2013) A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat. Genet., 45, 918-922.
15. Price,A.L. et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
16. Johnson,A.D. et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics, 24, 2938-2939.
17. Yu,K. et al. (2009) Pathway analysis by adaptive combination of P-values. Genet. Epidemiol., 33, 700-709.
18. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
19. Benjamin,Y., et al.(2006) Adaptive linear step-up procedures that control the false discovery rate. Biometrika., 93, 491-507.
20. Safaeian,M. et al. (2012) Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One, 7, e33619.
21. Sprenger,R., et al.(2000) Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics., 10, 557-565.
22. Wain,H.M. et al. (2002) Guidelines for human gene nomenclature. Genomics, 79, 464-470.
23. Alper,C.A. et al. (2006) The haplotype structure of the human major histocompatibility complex. Hum. Immunol., 67, 73-84.
24. Ghaderi,M. et al. (1999) MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia. Hum. Immunol., 60, 970-973.
25. Ghaderi,M. et al. (2001) Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum. Immunol., 62, 1153-1158